Goles, Nerie G.

HRN: 27 22 01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/19/2025
07/25/2025
IV
750mg
Q72hours
Vap
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: